Radiomics Analysis for (177)Lu-DOTAGA-(l-y)fk(Sub-KuE) Targeted Radioligand Therapy Dosimetry in Metastatic Prostate Cancer—A Model Based on Clinical Example

(177)Lu-DOTAGA-(l-y)fk(Sub-KuE) a.k.a. (177)Lu-PSMA I&T is currently used for radioligand therapy (RLT) of metastatic castration-resistant prostate cancer (mCRPC) in several centers in Europe. Background: Dosimetry is mandatory according to EU guidelines, although routine methods for dosimetry,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelk, Eve, Ruuge, Priit, Rohtla, Kristi, Poksi, Anne, Kairemo, Kalevi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926837/
https://www.ncbi.nlm.nih.gov/pubmed/33671761
http://dx.doi.org/10.3390/life11020170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926837/
https://www.ncbi.nlm.nih.gov/pubmed/33671761
http://dx.doi.org/10.3390/life11020170

Ejemplares similares